VTL Vital Therapies Inc.

0.26
0  0%
Previous Close 0.26
Open 0.25
Price To Book 0.76
Market Cap 10876300
Shares 42,369,694
Volume 584,442
Short Ratio
Av. Daily Volume 4,272,214

NewsSee all news

  1. Vital Therapies: 3Q Earnings Snapshot
  2. Vital Therapies Provides Strategic Update
  3. Today’s Research Reports on Stocks to Watch: Tonix Pharmaceuticals and Vital Therapies
  4. Vital Therapies to Present at the 19th International Liver Support Meeting
  5. Who Are Vital Therapies Inc’s (NASDAQ:VTL) Major Shareholders?

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181167728
  2. 8-K - Current report 181167718
  3. 8-K - Current report 181142166
  4. 8-K - Current report 181119135
  5. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 181074586

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released September 11, 2018 - endpoints not met.
VTI-308
Alcohol-induced liver decompensation, or AILD
Terminated September 2015 in order to reduce costs
ELAD (VTI-210)
Severe acute alcoholic hepatitis
Terminated September 2015 in order to reduce costs
ELAD (VTI-212)
Fulminant hepatic failure, or FHF, or surgery-induced acute liver failure, or SILF

Latest News

  1. Vital Therapies: 3Q Earnings Snapshot
  2. Vital Therapies Provides Strategic Update
  3. Today’s Research Reports on Stocks to Watch: Tonix Pharmaceuticals and Vital Therapies
  4. Vital Therapies to Present at the 19th International Liver Support Meeting
  5. Who Are Vital Therapies Inc’s (NASDAQ:VTL) Major Shareholders?
  6. Is the Options Market Predicting a Spike in Vital Therapies (VTL) Stock?
  7. Today’s Research Reports on Stocks to Watch: Bausch Health Companies and Vital Therapies
  8. 3 Biotech Stocks That Could Double Your Money
  9. William Blair Upgrades Vital Therapies Ahead Of September Liver Failure Data
  10. Are Options Traders Betting on a Big Move in Vital Therapies (VTL) Stock?

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181167728
  2. 8-K - Current report 181167718
  3. 8-K - Current report 181142166
  4. 8-K - Current report 181119135
  5. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 181074586
  6. 8-K - Current report 181069970
  7. 8-K - Current report 181065898
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 18998163
  9. 8-K - Current report 18997934
  10. EFFECT - Notice of Effectiveness 18898001